C
66.21
1.18 (1.81%)
| Previous Close | 65.03 |
| Open | 65.10 |
| Volume | 3,871,318 |
| Avg. Volume (3M) | 6,356,938 |
| Market Cap | 32,694,298,624 |
| Price / Earnings (Forward) | 17.24 |
| Price / Sales | 0.160 |
| Price / Book | 1.50 |
| 52 Weeks Range | |
| Earnings Date | 28 Jul 2026 |
| Profit Margin | 2.25% |
| Operating Margin (TTM) | 4.49% |
| Diluted EPS (TTM) | 6.78 |
| Quarterly Revenue Growth (YOY) | 16.60% |
| Quarterly Earnings Growth (YOY) | 12.70% |
| Total Debt/Equity (MRQ) | 65.38% |
| Current Ratio (MRQ) | 1.11 |
| Operating Cash Flow (TTM) | 2.12 B |
| Levered Free Cash Flow (TTM) | 2.51 B |
| Return on Assets (TTM) | 3.86% |
| Return on Equity (TTM) | 12.53% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Healthcare Plans (US) | Mixed | Bearish |
| Healthcare Plans (Global) | Mixed | Bearish | |
| Stock | Centene Corporation | Bullish | Bearish |
AIStockmoo Score
-0.6
| Analyst Consensus | -1.5 |
| Insider Activity | NA |
| Price Volatility | -5.0 |
| Technical Moving Averages | 0.0 |
| Technical Oscillators | 4.0 |
| Average | -0.63 |
|
Centene is a managed care organization that focuses on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 20 million medical members as of December 2025, mostly in Medicaid (about 64% of membership), the individual exchanges (about 28%), and Medicare (about 5%). The company also provides Medicare Part D pharmaceutical plans. |
|
| Sector | Healthcare |
| Industry | Healthcare Plans |
| Investment Style | Mid Core |
| % Held by Insiders | 0.46% |
| % Held by Institutions | 99.81% |
| 52 Weeks Range | ||
| Median | 41.00 (-38.08%) | |
| Total | 1 Hold | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| Mizuho | 11 Mar 2026 | 41.00 (-38.08%) | Hold | 35.86 |
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |